ANNOUNCEMENT

Join us at MedCity CONVERGE July 9-10 in Philadelphia, and hear from ALL healthcare innovation sectors.

SEO Social Media chart

September 18, 2012 3:14 pm by | 0 Comments

SEO Social Media chart

from big stock

http://www.bigstockphoto.com/image-34568273/stock-photo-seo-&-social-media-chart

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.

Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.

Related Topics:
Previous Story

Next Story

Veronica Combs

By Veronica Combs

I am the editor in chief at MedCityNews.com. I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012.
More posts by Author
0 comments
  Livefyre
Sort: Newest | Oldest

Stay Up To Date

Be the first to hear the latest industry news with our newsletters or by following us on Twitter & Facebook.

Recent

Power to the patients: Doc appointment and review website Vitals raises $22M

Power to the patients: Doc appointment and review website Vitals raises $22M

Healthcare leaders to Senate finance committee: “Transparency can only go so far”

Healthcare leaders to Senate finance committee: “Transparency can only go so far”

Medtronic’s bone growth product works as well as a traditional bone graft, but may be riskier

Medtronic’s bone growth product works as well as a traditional bone graft, but may be riskier

No short-term fixes for AstraZeneca, turnaround will take 3 to 4 years

No short-term fixes for AstraZeneca, turnaround will take 3 to 4 years

After two deaths, FDA investigates Lilly schizophrenia drug

After two deaths, FDA investigates Lilly schizophrenia drug